COVID-19-associated secondary sclerosing cholangitis - A case series of 4 patients.
Clin Res Hepatol Gastroenterol
; 46(10): 102048, 2022 Dec.
Article
in English
| MEDLINE | ID: covidwho-2259075
ABSTRACT
We report a case series of four patients diagnosed with COVID-19-associated secondary sclerosing cholangitis (SSC), a recently described rare late complication of severe COVID-19. Following prolonged stays in the intensive care unit, these patients developed marked sustained cholestasis and jaundice despite clinical improvement. Cholangiography showed beaded appearance of intra-hepatic bile ducts and bile casts were removed in one patient. None of the patients reached normalization of liver enzymes and at least one progressed to liver cirrhosis (follow-up time of 11 to 16 months). COVID-19-associated SSC has a dismal prognosis with rapid progression to advanced chronic liver disease.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Cholangitis, Sclerosing
/
Cholestasis
/
COVID-19
Type of study:
Case report
/
Cohort study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Clin Res Hepatol Gastroenterol
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS